Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light

This study has been completed.

First Received: February 6, 2007 No Changes Posted

Sponsored by:	Bispebjerg Hospital
Information provided by:	Bispebjerg Hospital
ClinicalTrials.gov Identifier:	NCT00432224

Purpose

The objective of the study is to evaluate the use of sunlight instead of red light during photodynamic therapy of actinic keratoses using methyl aminolevulinate

Condition	Intervention
Actinic Keratoses	Procedure: photodynamic therapy

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Safety/Efficacy Study

Further study details as provided by Bispebjerg Hospital:

Estimated Enrollment:	28
Study Start Date:	May 2006
Estimated Study Completion Date:	February 2007

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

symmetric actinic keratoses in scalp or face

Exclusion Criteria:

porphyria, pregnancy, breast feeding

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00432224

Locations

Denmark
Bispebjerg Hospital
Copenhagen NV, Denmark, 2400

Sponsors and Collaborators

Bispebjerg Hospital

Investigators

Study Director:	Hans Christian Wulf, Professor, MD	Bispebjerg Hospital
Study Chair:	Merete Hædersdal, MD, PhD	Bispebjerg Hospital

More Information

No publications provided

Study ID Numbers:	KF 01-272867
Study First Received:	February 6, 2007
Last Updated:	February 6, 2007
ClinicalTrials.gov Identifier:	NCT00432224 History of Changes
Health Authority:	Denmark: Danish institute of health

Study placed in the following topic categories:

Keratosis
Skin Diseases
Tylosis

Additional relevant MeSH terms:

Keratosis
Skin Diseases

ClinicalTrials.gov processed this record on September 02, 2009